TOKYO, Jun 25 (Pulse News Wire) – Matsuya R&D Co.,ltd (7317.T) announced changes in controlling shareholders following the completion of Omron Healthcare Co., Ltd.’s open offer acquisition of the company’s ordinary shares and subscription rights on June 15, 2026. As a result, Omron Healthcare Co., Ltd.
Became the parent company effective June 19, 2026, holding 95.88% of the voting rights. Omron Corporation, the parent company of Omron Healthcare Co., Ltd., also indirectly holds shares through Omron Healthcare, making it a parent company of Matsuya R&D Co.,ltd Following the open offer, former controlling shareholders Mr. Hideaki Gotō and Mr.
Masahiro Gotō divested their entire holdings, ceasing to be controlling shareholders as of June 19, 2026. The company's capital structure now stands as follows: - Omron Healthcare Co., Ltd.: Parent Company, 95.88% - Omron Corporation: Parent Company, 95.88% This shift was detailed in the open offer results announced on June 19, 2026, marking a significant change in the company's governance structure. In addition, Matsuya R&D Co.,ltd maintains a policy against transactions with controlling shareholders and their close relatives, ensuring minority shareholder protections through rigorous review processes involving external directors and auditors.
🟢 Confidence: High AI-translated content.